Press "Enter" to skip to content

Thrombectomy Devices Market Size, Industry Trends, Historical Data, Growth Analysis Forecast to 2030

The global thrombectomy devices market size was worth around USD 1.35 Billion in 2021 and is estimated to grow to about USD 2.12 Billion by 2030, with a compound annual growth rate (CAGR) of approximately 6.9% over the forecast period.

???? Click Here to access The Full market Report :

➤ The global market is expected to experience a growth in demand for stent retrievers.

Stent retrievers are mechanical thrombectomy products from the second generation that are employed to treat thrombotic diseases. For the precise implantation of the stent at the occlusion site, a balloon-expanding or self-expanding stent is connected to a Guidewire in-stent retrieval device. The stent is positioned at the occlusion site and the thrombus is covered by inflating the stent body. A stent extraction device is then employed to thoroughly remove the thrombus.

➤ The market’s expansion may be hindered by a scarcity of expertise.

In the sphere of medical devices, it is imperative to have professionals who possess the necessary knowledge of the device. The diagnosis of the disease is crucial for the patient’s treatment; therefore, providers must ensure that the diagnosis is accurate and includes the appropriate data and images. The market growth may be impeded by a decrease in the use of thrombectomy devices, which may be a result of the absence of training in low and middle-income countries and the increase in technological advancements. Furthermore, the market growth may be impeded by stringent regulatory bodies, a lack of awareness among the populace regarding the advantages of thrombectomy devices, and inadequate healthcare infrastructure in rural areas and underdeveloped countries.

➤ During the forecast period, the market will be driven by the implementation of AI in medical devices and technological advancement.

Mechanical thrombectomy devices, which are directed from the wrist or groin through a wire to the obstruction, can be employed to treat acute ischemic stroke, a primary cause of long-term impairment. The patient’s prognosis must be improved by removal of the thrombus as soon as possible.

➤ Vascular damage may result from repeated passages by the thrombectomy device.

Vascular injury, including vascular re-occlusion, endothelial denudation, and microembolization of distant branches, may result from the repeated use of a thrombectomy device. These complications could have severe repercussions on a patient’s neurological recovery. The pro-thrombotic environment may be exacerbated by microscopic injury to deep atheroma plaques in the intracerebral circulation of the elderly. The use of thrombectomy devices is significantly impacted by these factors, which pose a significant challenge for both manufacturers and providers.

???? Get more info :

The Global Thrombectomy Devices Market is segmented based on product, application and region

Global Thrombectomy Devices Market: Product Segment Analysis

● Automated Devices
● Manual Devices

Global Thrombectomy Devices Market: Application Segment Analysis

● Peripheral Diseases
● Coronary Diseases
● Neural Diseases

Click on This Below Link to see Similar Reports :

The global Thrombectomy Devices market profiles key players such as:

● Stryker Corporation
● Medtronic plc.
● Boston Scientific Corporation
● Terumo Corporation
● Penumbra Inc.
● Johnson & Johnson
● Spectranetics Corporation
● Teleflex Incorporated
● AngioDynamics Inc.
● Bayer AG
● Merit Medical Systems
● Phenox Gmbh
● Philips Healthcare

???? Recent Developments:

• Cardiovascular Systems, Inc., an innovative medical device company, announced in February 2022 that they have partnered with Innova Vascular, Inc., a creative medical device startup that is dedicated to the development of breakthrough medical devices with a minimally invasive approach, to create a line of thrombectomy devices that are effective. They endeavor to create mechanical devices and aspiration devices that are effective in the treatment of a variety of diseases, including pulmonary embolism, peripheral vascular disease, and deep vein thrombosis.

• In July 2021, Surmodics, Inc., a leading provider of medical devices and in vitro diagnostic technologies, announced the acquisition of Vetex Medical Limited, a medical device provider based in Ireland. The acquisition broadens Surmodics’ product line to include mechanical thrombectomy devices that are both U.S. Food and Drug Administration (FDA) cleared and entirely effective. Their devices are specifically engineered to address a variety of acute conditions, such as arterial and venous thrombosis.

➤ In 2021, the North American region accounted for the greatest market share and is expected to experience a substantial compound annual growth rate (CAGR).

North America dominated the global thrombectomy devices market, accounting for more than 39% of the market. It is anticipated that the United States will continue to be the primary source of revenue in the North American market. Technical advancements in devices to achieve superior clinical outcomes, the growing burden of cardiac patients, and the growing demand for less invasive solutions are all contributing to the growth of the thrombectomy devices market in the United States.

???? Get Customization Report :

About Us :

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database.

Contact Us:

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651
Email: [email protected]

Ritesh Author
Sorry! The Author has not filled his profile.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *